Summary
Neuropeptides have been a subject of considerable interest in the pharmaceutical industry over the last 20 years or more. Many drug discovery teams have contributed to our understanding of neuropeptide biology but no significant drugs that act selectively upon neuropeptide receptors have yet emerged from the clinic. There are, however, a plethora of clinically useful drugs that act at other classes of neurotransmitter and neuromodulator receptors, many of them discovered over the last 20 years. Nevertheless, we think that the future for the discovery of novel drugs acting at neuropeptide receptors looks bright for two reasons: (1) there has been a substantial increase in our understanding of the function of neuropeptides; and (2) high-throughput screening (HTS) against neuropeptide receptors has now begun to yield many interesting drug-like molecules, rather than peptides, that have the potential to become clinically useful drugs.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Klaviedva, M.M.: Frontiers Neuroendocrinol.16293–321 (1995).
Iversen, L.L.: Trends Neurosci.115–16 (1978).
Iversen, L.L.: Trends Neurosci.1849–50 (1995).
Shaw, C.: Parasitol.113S35–45 (1996).
Horwell, D.C.: Trends Biotechnol.13132–134 (1995).
Kenny, B.A., Bushfield, M., Parry-Smith, DJ., Fogarty, S. and Treherne, J.M.: Progress in Drug Research51246–269 (1998)
Prokai, L.: Progress in Drug Research5195–131 (1998).
Hokfelt, T., Broberger, C., Zhang, X., Diez, M., Koop, J., Xu, Z., Landry, M., Bao, L., Schalling, M., Koistinaho, J. et al.: Brain Research Reviews26154–166 (1998).
Malendowicz, L., Markowska, A. and Zabel, M.: Histol. Histopathol.11485–494 (1996).
Broberger, C., Johansen, J., Schalling, M. and Hokfelt, T: J. Comp. Neurol.387124–135 (1997).
Tritos, N., Vicent, D., Gillette, J., Ludwig, D., Flier, E. and Maratos-Flier, E.: Diabetes471687–1692 (1998).
Krstenansky, J., Owens, T., Buck, S., Hagaman, K. and McLean, L.: Proc. Natl. Acad. Sci.864377–4381 (1989).
Jacques, D., Cadieux, A., Dumont, Y. and Quirion, R.:Eur. J. Pharm.278, R3–R5 (1995).
Kawasaki, A., Knapp, R., Kramer, T., Wire, W., Vasques, O., Yamamura, H., Burks, T. and Hruby, V.: J. Med. Chem. 33, 1874–1879 (1990).
Meyer, J., Collins, N., Lung, F., Davis, P., Zalewska, T., Porreca, F., Yamamura, H. and Hruby, V.: J. Med. Chem.373910–3917 (1994).
Chen, H., Nobel, F., Coric, P., Fournie-Zaluski, M. and Rogues, B.: Proc. Nat. Acad. Sci.9512028–12033 (1998).
Prokai-Tatrai, K., Prokai, L. and Bodor, N.: J. Med. Chem.394775–4782 (1996).
Horwell, D.: Neuropeptides1957–64 (1991).
Menani, J. and Johnson, A.: Am J. Physiol.275R1421–R1437 (1998).
Sohal, V., Cox, C. and Huguenard, J.: J. Neurophysiol.792820–2824 (1998).
Makovec, F., Penis, W., Frigerio, S., Giovanetti, R., Letari, O., Mennui, L. and Revel, L.:J. Med. Chem.39, 135–142 (1996).
Freidinger R.M., Bock M.G., DiPardo R.M., Evans B.E., Rittle K.E., Whitter W.L., Veber D.E. Anderson P.S., Chang R.S.L. and Lotti V.J. in: Hughes, Dockary & Woodruff: The Neuropeptide Cholecystokinin, Ellis Horwood Ltd, 123–132, 1998.
Freedman S.B., Patel S., Smith A.J., Chapman K., Fletcher A., Kemp J.A., Marshall G.R., Hargreaves R.J., Scholey K., Mellin E.C.et al.,in: Reeve, Eysselein, Solomon and Laing: Cholecystokinin, Ann. Acad. Sci.713312–330, 1994.
Nussdorfer, G. and Malendowicz, L.:Peptides19, 949–968 (1998).
Ku, Y., Tan, L., Li, L. and Ding, X.:Peptides19, 677–682 (1998).
Hasenohrol, R., Jentjens O., De Souza-Silva, M., Tomaz, C. and Huston, J.: Eur J. Phama-col.354123–133 (1998).
Tang, F., Chiu, T. and Wang, Y.: Experimental. Neurol.15241–49 (1998).
Bell, M., Richardson, P. and Lee, K.: Neurosci. 87, 649–658 (1998).
Wang, X. and Robertson, D.: J. Neurophysiol.80218–229 (1998).
Shen, K.Z and North, R.A.: Neurosci. 50, 345, (1992).
Koyano, K., Velimirovic, B.M., Grigg, J.J., Nakajima, S. and Nakajima, Y.: Eur. J. Neurosci.51189 (1993)
Lieberman, D. and Mody, I.: J. Neurophysiol.80113–119 (1998).
Bartfai, T., Iverfeldt, K., Fisone, G. and Serofozo, P.: Ann. Rev. Pharmacol. Toxicol.28285–310 (1988).
Seutin, V., Verbanck, P., Massotte, L. and Dresse, A.: Eur J. Pharmacol.164373–376 (1989).
Gopalan, C., Tian, Y., Moore, D. and Lookingland, K.: Neuroendocrinol.58287–293 (1993).
Weiss, J., Demetrikopoulos, M., West, C. and Bonsall, R.: Depression3225–245 (1995).
Demetrikopoulos, M.K., Kreiss, J.H., Turner, A.J., Koski, P.A., Bonsall, R.W. and Weiss J.M.: Soc. Neurosci. Abstr.22812–818 (1996).
Kiss, A. and Jezova, D.: Histochem. J.30569–575 (1998).
Consolo, S., Uboldi, M., Caltavuturo, C. and Bartfai, T.:Neurosci. 85, 819–826 (1998).
Sobreviela, T., Jaffar, S. and Mufson, E.:Neurosci.87, 447–461 (1998).
Barbelivien, A., MacKenzie, E. and Dauphin, F.:Brain Res.789, 92–100 (1998).
Connor, B. and Dragunow, M.: Brain Res. Rev.271–39 (1998).
Marowska, A., Mooney, M. and Sonntag, W.:Neurosci. 87, 559–569 (1998).
Haller, M. and Saltzman, W.:Pharmaceutical Res.15, 377–385 (1998).
Van Rossum, D., Hanisch, U. and Quirion, R.: Neurosci and Biobehay. Rev.21649–678 (1997).
Ma, W. and Bisby, M.: Exp. Neurology152137–149 (1998).
Wimalawansa, SJ.: Endocrin Rev.17533–585 (1996).
Huhman, K., Gillespie, C., Marvel, C. and Albers, H.: Ann. N. Y. Acad. Sci.814300–304 (1997).
Quirion, R. and Dumont, Y., in: D.R. Poyner, I. Marshall, I. and S.D. Brain (ed.): The CGRP family: CGRP, amylin and adrenomedullin. Landes Biosciences, Texas 2000.
Marshall, I., Poyner, D.R., Sexton, P.M. and Smith, D.M.: Trends Pharmacol. Sci. (Nomen-clature supplement), 5th edition, 20–21 (1999).
Dennis, T.B., Fournier, A. St. Pierre, S. and Quirion, R.: J. Pharmacol. Exp. Ther.251718–725 (1989).
Quirion, R., Van Rossum, D., Dumont, Y., St. Pierre, S. and Fournier, A.: Ann. N.Y. Acad. Sci.65788–105 (1992).
Poyner, D.R.: Biochem. Soc.Trans.251032–1036 (1997).
Aiyar, N., Rand, K., Elshourbagy, N.A., Zeng, Z.Z., Adamou, J.E., Bergsma, D.J. and Li, Y.: J. Biol. Chem.27111325–11329 (1996).
McLachtie, L.M., Fraser, N.J., Main, MJ., Wise, A., Brown, J., Thompson, N., Solari, R., Lee, M.G. and Foord, S.M.: Nature393333–339 (1998).
Daines, R.A., Sham, K.K.C., Taggart, J.J., Kingsbury, W.D, Chan, J., Breen, A., Disa, J. and Aiyar, N.: Bioorg. Med. Chem. Lett.72673–2676 (1997).
Shawket, S., Dickerson C., Hazleman, B and Brown M.J.: Brit. J. Clin. Pharmacol.32209–213 (1991).
Bennett, G.S., Radhika Kajekar, R., Garrett, N.E., Diemel, LT, Tomlinson, D.R. and Brain, S.D., in: D.R. Poyner, I. Marshall and S.D. Brain (eds.): The CGRP family: CGRP, amylin and adrenomedullin. Landes Biosciences, Texas 2000.
Johnston, F.G., Bell, B.A., Robertson, I.J., Miller, J.D., Hailburn, C., O’Shaughnessy, D., Riddell, A.J. and O’Laoire, S.A.: Lancet335869–872 (1990).
Bailey, I.C., Lyttle, J.A., Matthew, B., Braadvedt, G., Nelson, RJ., Stranjalis, G., Castel, J.P., Orgogozo, J.M., Aziz, A.M., Buckley, T.F. et al.: Lancet339831–834 (1992).
Uren, N.G., Seydoux, C. and Davies, GJ.: Cardiovasc. Res.271477–1488 (1993).
Uren, N.G., Ludman, P.F., Crake, T. and Oakley, C.M.: J. Am. Coll. Cardiol.19835–841 (1992).
Goadsby, P.J., in: D.R. Poyner, I. Marshall and S.D. Brain (eds.): The CGRP family: CGRP, amylin and adrenomedullin. Landes Biosciences, Texas 2000.
Stones, R.W., Thomas, D.C. and Beard, R.W.: Clin. Auton. Res.2343–348 (1992).
Dubisrande, J.L., Merlet, P., Benveniste, C., Sediame, S., Macquinmavier, I., Charbier, E., Braquet, P., Castaigne, A. and Adnot, S.: Am. J. Cardiol.70906–912 (1992).
Stevenson, R.N., Roberts, R.H. and Timmis, A.D.: Int. J. Cardiol.37407–414 (1993).
McGillis, J.P. and Figueiredo, H.F., in: J.A. Marsh and MD. Kendall (eds.): The Physiology of Immunity, CRC Press, London 1996, 127–143
Brain, S.D.: Immunopharmacol.37133–152, (1997).
Furness, J.B. and Costa, M.: The Enteric Nervous System, ed. 1, Churchill Livingstone, New York 1987.
Furness, J.B., Costa, M., Gibbins, I.L., Llewellyn-Smith, I.J. and Oliver, J.R.: Cell Tiss. Res.241155–163 (1985).
Ekblad, E., Winter, C., Ekman, E., Wakanson, R. and Sundler, F.: Neurosci.20169–188, (1987).
Ekblad, E., Ekman, R., Hakanson, R. and Sundler, F.:Neurosci. 27, 655–674 (1987).
Gershon, M.D., Kirchgessner, A.L. and Wade, P.R., in: R. Leonard: Physiology of the Gas-trointestinal Tract, Raven Press, New York 1994, vol.1381–414.
Cox, H.M., Rudolph, A. and Gschmeissner, S.: Neurosci.59:469–476 (1994).
Portbury, A.L., Furness, J.B., Southwell, B.A., Wong, H., Walsh, J.H. and Bunnett, N.W.: Cell & Tissue Res.286:281–292 (1996).
Saffrey, M.J. and Burnstock, G.: J. Autonom. Nerv. System.49183–196 (1994).
Belai, A. and Burnstock, G.: Gastroenterol.98:1427–1436 (1990).
Goyal, R.K. and Hirano, I.: New Engl. J. Med.3341106–1115 (1996).
Grandt, D., Schimiczek, M., Beglinger, C., Layer, P., Goebell, H., Eysselein, V.E. and Reeve, J.R.: Reg. Peptides51151–159 (1994).
Wattchow, D.A., Furness, J.B., Costa, M., O’Brien, P.E. and Peacock, M.: Gastroenterol.93: 1363–1371 (1987).
Browning, K.N. and Lees, G.M.:Neurosci.62:1257–1266 (1994).
Bottcher, G, Sjolund, K., Ekblad, E., Hakanson, R., Schwartz, T. and Sundler, F.:Reg. Pep-tides8, 261–266 (1984).
Pappas, T.N., Chang, A.M., Debas, H.T. and Taylor, I.L.:Gastroenterol.91,1386–1389 (1986).
Playford, RJ., Domin, J., Beacham, J., Parmar, K.B., Tatemoto, K., Bloom, S.A. et al.: Lancet3351555–1557 (1990).
Holzer-Petsche, U., Petritsch, W., Hinterleitner, T., Eherer, A., Sperk, G. and Krejs, G.J.:Gastroenterol. 101, 325–330 (1991).
Playford, R.J. and Cox, H.M.: Trends Pharmacol. Sci.17436–438 (1996).
Walsh, J.H., in: L.R. Johnson (ed.): Physiology of the Gastrointestinal Tract, Raven Press New York 1994, vol.11–128.
Stanley, B.G., Daniel, D.R., Chin, A.S. and Leibowitz, S.F.: Peptides61205–1211 (1985).
O’Shea, D., Morgan, D.G.A., Meeran, K., Smith, D.M., Ghatei, M.A. and Bloom, S.R.: Endocrinol.138196–202 (1987).
Stephens, T.W., Basinski, M., Bristow, P.K., Zhang, X.-Y. and Heiman, M.: Nature377530–532 (1995).
Michel, M.C., Beck-Sickinger, A., Cox, H.M., Doods, H.N., Herzog, H., Larhammar, D., Quirion, R., Schwartz, T.W. and Westfall, T.: XVI. Pharmacol Rev.50143–150 (1998).
Cox, H.M., in: W. Colmers and C. Wahlestedt (eds): The biology of NPY and related pep-tides, Humana Press Inc., New Jersey 1993, 273–313
Saria, A. and Beubler, E.: Eur. J. Pharmacol.11947–52 (1995).
Cox, H.M., Cuthbert, A.W., Hakanson, R. and Wahlestedt, C.: J. Physiol.39865–80 (1998).
Strabel, D. and Diener, M.: Br. J. Pharmacol.1151071–1079 (1995).
Tough, I.R. and Cox, H.M.: Eur. J. Pharmacol.31055–60 (1996).
Holzer, P., Lippe, I.T., Bartho, L. and Saria, A.: Gastroenterol.921944–1950 (1997).
Krantis, A., Potvin, W. and Harding, R.K.: Naunyn-Schmeid. Arch. Pharmacol.338287–292 (1998).
Cox, H.M. and Cuthbert, A.W.: Br. J. Pharmacol.101247–252 (1990).
Cox, H.M. and Krstenansky, J.L.:Peptides12323–327 (1991).
Servin, A.L., Rouyer-Fessard, C., Balasubramanian, A., St-Pierre, S. and Laburthe, M.:Endocrinol.124, 692–700 (1989).
Gehlert, D.R., Beavers, L.S., Johnson, D., Gackenheimer, S.L., Schober, D.A. and Gadski, R.A.: Mol. Pharmacol.49224–228 (1996).
Blomqvist, A. and Herzog, H.:Trends Neurosci.20, 294–298 (1997).
Wharton, J., Gordon, L., Byrne, J., Herzog, H., Selbie, L.A., Moore, K. et al.: Proc. Natl. Acad. Sci.90687–691 (1993).
Lundell, I., Blomqvist, A., Berglund, M.M., Schober, D.A., Johnson, D., Statnick, M.A., Gadski, R.A., Gehlert, D.R. and Larhammar, D.: J. Biol. Chem.27029123–29128 (1995).
Cox, H.M. and Tough, I.R.: Br. J. Pharmacol.1162673–2678 (1995).
Mannon, P.J., Mervin, S.J. and Sheriff-Carter, K.D.: Am. J. Pharmacol.267G901–G907 (1994).
Gingerich, R.L., Akpan, J.O., Gilbert, W.R., Leith, K.M., Hoffman, J.A. and Chance, R.E.:Am. J. Physiol. 261, E319–324 (1991).
Holliday, N.D. and Cox, H.M.: Br. J. Pharmacol.119321–329 (1996).
Holliday, N.D. and Cox, H.M.: Br. J. Pharmacol.120290P (1997).
Mentlein, R., Dahms, P., Grandt, D. and Kruger, R.: Reg. Peptides49133–144 (1993).
Howell, S., Kenny, A.J. and Turner, A.J.: Biochem. J.284595–601 (1992).
Holliday, N.D. and Cox, H.M.: Reg. Peptides71Pll (1997).
Ballantyne, G.H., Goldenring, J.R., Fleming, F.X., Rush, S., Flint, J.S., Fielding, L.F., Binder, H.J. and Modlin, I.M.: Am. J. Physiol.264G848–G854 (1993).
Walsh, D.A., Wharton, J., Blake, D.R. and Polak, J.M.: Br. J. Pharmacol.108304–311 (1993).
Doods, H., Gaida, W., Wieland, H.A., Dollinger, H., Schnorrenberg, G., Esser, F., Engel, W., Eberlein, W. and Rudolf, K.: Eur. J. Pharmacol. (in press).
Criscione, L., Rigollier, P., Batzl-Hartman, C., Rueger, H. et al.: J. Clin. Invest.1022136–2145 (1998)
Darlinson, M.G. and Richter, D.:Trends Neurosci.22, 81–88 (1999).
Okuda-Ashitaka, E.: Nature392286–289 (1998).
De Lecea, L.: Proc. Nat. Acad. Sci. U.S.A.95322–327 (1998).
Sakurai, T.: Cell92573–585 (1998).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2000 Springer Basel AG
About this chapter
Cite this chapter
Poyner, D., Cox, H., Bushfield, M., Treherne, J.M., Demetrikopoulos, M.K. (2000). Neuropeptides in drug research. In: Jucker, E. (eds) Progress in Drug Research. Progress in Drug Research, vol 54. Birkhäuser, Basel. https://doi.org/10.1007/978-3-0348-8391-7_4
Download citation
DOI: https://doi.org/10.1007/978-3-0348-8391-7_4
Publisher Name: Birkhäuser, Basel
Print ISBN: 978-3-0348-9546-0
Online ISBN: 978-3-0348-8391-7
eBook Packages: Springer Book Archive